Dear Global Pharma News Members,
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
About Company :
Shri Ramesh Babu Potluri, Chairman and Managing Director – A Visionary in pharma industry started SMS Pharmaceuticals Ltd in the year 1990 taking over a sick facility and turning it around by changing of products within no time. From a single unit and single product entity SMS grew into multiple facilities and multiple products group having customer base in more than 70 countries.
Srinivasulu Tirumalasetty
Emp Id : 29489
If any one coming with my reference Whats app 9581392181
For more updates follow
To get global pharma news updates in whatsapp please
ABOUT COMPANY :
Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
To get global pharma news updates in whatsapp please
Jodas is a Global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
· Anti Infectives (Injectables & Orals)
· Anti Cancer (Injectables & Orals)
· Contrast Media – Injectables
· Critical Care (Injectables & Orals)
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.
Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.
We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.
Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.
For more updates follow
To get global pharma news updates in whatsapp please
ABOUT COMPANY :
Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.
As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
For more updates follow
To get global pharma news updates in whatsapp please
